GSK plc (GSK) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-04 19:30:43 ET
GSK plc (GSK) Q4 2025 Earnings Call February 4, 2026 6:00 AM EST
Company Participants
Luke Miels - CEO & Director
Nina Mojas
Deborah Waterhouse - CEO of ViiV Healthcare & President of Global Health
Tony Wood - Chief Scientific Officer and Head of R&D
Julie Brown - CFO & Executive Director
...
Read the full article on Seeking Alpha
For further details see:
GSK plc (GSK) Q4 2025 Earnings Call Transcript
GlaxoSmithKline Plc
NASDAQ: GLAXF
GLAXF Trading
-1.49% G/L:
$27.04 Last:
200 Volume:
$27.04 Open:
GLAXF Latest News
GLAXF Stock Data
$123,941,620,346
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
